Synthetic Biologics

 
Stock Quotes for Synthetic Biologics top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Slow Growth
Sign-up for syn investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Slow Growth
Sign-up for syn investment picks

 
News Articles for Synthetic Biologics top ^
2014/11/14
-- Company Completes $18.9 Million Net Registered Direct Offering; Finalizes Plans for Start of Clinical Trials in C.
Sign-up for Synthetic Biologics Reports Third Quarter 2014 Financial Results and Operational Highlights investment picks
-- Phase 1a and 1b Trials to Use SYN-004 to Protect Microbiome; Intended to Prevent Overgrowth of Potentially Deadly C.
Sign-up for Synthetic Biologics Safe-to-Proceed Under IND to Initiate Clinical Trials of SYN-004 for the Prevention C. difficile Infection investment picks
-- First-in-Class Clinical Program Targets Protection of Microbiome to Prevent Overgrowth of Deadly C.
Sign-up for Synthetic Biologics Announces First Patient Dosed in Phase 1a Clinical Trial of SYN-004 for the Prevention of C. difficile Infection investment picks
2014/10/22
-- First Allowed Patent Application Directly Related to SYN-004 in the U.S. -- ROCKVILLE, Md.
Sign-up for Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program investment picks
-- Mark Pimentel, M.D., FRCP(C), of Cedars-Sinai Medical Center Serves as Chairman --
Sign-up for Synthetic Biologics Appoints Prominent Gastrointestinal (GI) Key Opinion Leaders to Irritable Bowel Syndrome (IBS) Clinical Advisory Board investment picks
-- Mark Pimentel, M.D., of Cedars-Sinai Delivered Keynote Presentation on Mechanism of Action --
Sign-up for Synthetic Biologics' Statin-Class Candidate for Constipation-Predominant Irritable Bowel Syndrome Detailed at Company's Investor Day investment picks
2014/10/10
ROCKVILLE, Md.
Sign-up for Synthetic Biologics to Raise $20.7 Million in Registered Direct Offering investment picks
2014/11/6
-- Conference Call Scheduled for Friday, November 14, 2014, at 8:30 a.m. EST --
Sign-up for Synthetic Biologics to Report Third Quarter 2014 Financial Results investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Synthetic Biologics
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Synthesis Energy Systems  |  Next: Synthetic Fibers